PreprintAll rights reservedbioRxiv
Novel retinoic acid receptor-related orphan receptor gamma inverse agonist enhances checkpoint blockade in hepatocellular carcinoma: a preclinical mouse study
- 1RI-MUHC
Related
- Marked Response to Nivolumab Plus Ipilimumab After the Failure of Two Prior Immune Checkpoint Inhibitor–Based Regimens Including CTLA-4 Blockade in Advanced Hepatocellular Carcinoma
- MYC Suppresses Mitochondrial Function in Hepatocellular Carcinoma through NRF1-Driven Receptor-Mediated Mitophagy
- Hepatic arterial infusion chemotherapy plus lenvatinib and programmed death receptor 1 inhibitor for hepatocellular carcinoma with portal vein tumor thrombosis: a prospective controlled study
- Mechanisms of Resistance and Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Narrative Review.
- Low CT-derived vertebral attenuation as a prognostic factor in hepatocellular carcinoma patients treated with immune checkpoint inhibitors
BibTeX
@misc{leo2026novel,
title = {{Novel retinoic acid receptor-related orphan receptor gamma inverse agonist enhances checkpoint blockade in hepatocellular carcinoma: a preclinical mouse study}},
author = {S. Leo and I. Dhoparee-Doomah and S. Negi and A. Fouda and F. Bourdeau and G. Evaristo and S. Paraskevas and J. Cools-Lartigue and J. Tchervenkov},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.13.758999},
url = {https://www.biorxiv.org/content/10.64898/2026.10.13.758999v1},
}
RIS
TY - UNPB
TI - Novel retinoic acid receptor-related orphan receptor gamma inverse agonist enhances checkpoint blockade in hepatocellular carcinoma: a preclinical mouse study
AU - S. Leo
AU - I. Dhoparee-Doomah
AU - S. Negi
AU - A. Fouda
AU - F. Bourdeau
AU - G. Evaristo
AU - S. Paraskevas
AU - J. Cools-Lartigue
AU - J. Tchervenkov
PY - 2026
DA - 2026/10/13
PB - bioRxiv
DO - 10.64898/2026.10.13.758999
UR - https://www.biorxiv.org/content/10.64898/2026.10.13.758999v1
ER -